The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management
This article reviews evidence that tetrahydrocannabivarin (THCV), a non-psychoactive compound from Cannabis sativa, may help with obesity and type 2 diabetes. In lab and animal studies THCV reduced appetite, improved insulin sensitivity and glucose uptake, lowered fat buildup, and boosted energy function in fat and liver cells. Early human trials…